17-61869139-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001351695.2(INTS2):āc.3139A>Cā(p.Ile1047Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000279 in 1,431,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001351695.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INTS2 | NM_001351695.2 | c.3139A>C | p.Ile1047Leu | missense_variant, splice_region_variant | 23/25 | ENST00000251334.7 | NP_001338624.2 | |
INTS2 | NM_020748.4 | c.3163A>C | p.Ile1055Leu | missense_variant, splice_region_variant | 23/25 | NP_065799.2 | ||
INTS2 | NM_001330417.2 | c.3139A>C | p.Ile1047Leu | missense_variant, splice_region_variant | 23/25 | NP_001317346.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INTS2 | ENST00000251334.7 | c.3139A>C | p.Ile1047Leu | missense_variant, splice_region_variant | 23/25 | 2 | NM_001351695.2 | ENSP00000251334.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000279 AC: 4AN: 1431598Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 713730
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.3163A>C (p.I1055L) alteration is located in exon 23 (coding exon 23) of the INTS2 gene. This alteration results from a A to C substitution at nucleotide position 3163, causing the isoleucine (I) at amino acid position 1055 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.